1xur: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The paradigm for matrix metalloprotease inhibition combines active site | The paradigm for matrix metalloprotease inhibition combines active site tailoring and catalytic zinc ligation. But, selectivity has been difficult. Now, Engel et al. present novel compounds, completely selective for MMP-13, with a unique binding mode. | ||
==About this Structure== | ==About this Structure== | ||
| Line 13: | Line 13: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Engel, C | [[Category: Engel, C K.]] | ||
[[Category: Wendt, K | [[Category: Wendt, K U.]] | ||
[[Category: CA]] | [[Category: CA]] | ||
[[Category: PB5]] | [[Category: PB5]] | ||
| Line 21: | Line 21: | ||
[[Category: non-zinc binding inhibitor]] | [[Category: non-zinc binding inhibitor]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:59:01 2008'' | ||
